反思弗莱明的警告:利益相关者决策对抗菌素耐药性演变的影响
Tom Ashfield1, Mineli Cooray2, Isabel Jimenez-Acha3
1The Signpost, Winchester, Hampshire, UK.
Microbiology (Reading, England)
|February 26, 2025
概括
抗微生物药物耐药性是一个主要的全球威胁. 将进化论纳入政策和利益相关方的决策,特别是对于β-乳糖抗生素,对于可持续的解决方案至关重要.
科学领域:
- 进化生物学是进化的生物学.
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 是对全球健康,环境和粮食安全的迫在眉的威胁,需要采取紧急反应.
- 当前的抗菌药物耐药性策略往往侧重于感染控制和管理等近距离问题,忽视了政策和利益相关者决定对抗药性演变的影响.
- 历史上的警告,比如弗莱明在1945年关于滥用青素的警告,强调了不负责任的抗菌药物使用的长期风险.
研究的目的:
- 批判性地评估影响抗微生物药物开发,生产和利用的历史决策过程.
- 证明政策和利益相关者的行为对抗菌素耐药性演变的根本影响.
- 通过将进化论纳入政策和实践,提出可持续的方法来制抗性进化.
主要方法:
- 专注于beta-lactam抗生素,这是最大的类别,具有显著的临床和经济影响.
- 检查了详细介绍β-乳酸的开发,生产,批准和利用的历史案例研究.
- 相关的利益相关者决策与观察到的抵抗演变模式.
主要成果:
- 历史分析显示,利益相关者的决策显著影响了耐药性演变.
- 过去对beta-lactam管理的方法为当前AMR危机缓解提供了关键的教训.
- 在将进化论纳入有关抗微生物药物的政策和行业实践方面存在差距.
结论:
- 将进化论纳入政策,行业和监管机构是有效打击抗菌素耐药性的必要条件.
- 预测和适应性政策,以历史评估为基础,可以制抗药的演变.
- 可持续的方法需要将进化原则纳入抗微生物药物的开发,生产和管理.
更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
06:54Enhanced Extraction of Low-Molecular Weight DNA from Wastewater for Comprehensive Assessment of Antimicrobial Resistance
Published on: July 19, 2024
相关概念视频
00:57Antibiotic Selection
Overview
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...